Future of COX2 inhibitors

被引：0
|
作者：
Irena Melnikova
机构：
[1] Ph.D.,
[2] is a Vice President at MEDACorp,undefined
来源：
Nature Reviews Drug Discovery | 2005年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 454
页数：1
相关论文
共 50 条
  • [1] Future of COX2 inhibitors
    Melnikova, I
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (06) : 453 - 454
  • [2] The development of COX2 inhibitors
    Flower, RJ
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (03) : 179 - 191
  • [3] The development of COX2 inhibitors
    Rod J. Flower
    [J]. Nature Reviews Drug Discovery, 2003, 2 : 179 - 191
  • [4] Chemoprevention with COX2 inhibitors?
    [J]. Nature Reviews Cancer, 2006, 6 (10) : 748 - 748
  • [5] Characteristics of COX2 inhibitors questioned
    Sophie Petit-Zeman
    [J]. Nature Reviews Drug Discovery, 2004, 3 : 726 - 726
  • [6] Characteristics of COX2 inhibitors questioned
    Petit-Zeman, S
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (09) : 726 - 727
  • [7] Have Cox2 inhibitors lived up to expectations?
    Kwong, MF
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 : 13 - 16
  • [8] COX2 inhibitors for acquired brain injuries: Is the time ripe?
    Strauss, Kenneth I.
    [J]. CRITICAL CARE MEDICINE, 2010, 38 (02) : 723 - 724
  • [9] Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain
    Strauss, Kenneth I.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2008, 22 (03) : 285 - 298
  • [10] Prevalence of COX2 expression in Middle Eastern CRC and the effect of COX2 inhibitors on cell growth in the mouse model of CRC
    Ahmed, Maqbool
    Bavi, Prashant
    Hussain, Azhar
    Al-Sanea, Nasser
    Abduljabbar, Alaa
    Ashari, Luai
    Alhomoud, Samar
    Al-Dayel, Fouad
    Uddin, Shahab
    Al-Kuraya, Khawla
    [J]. CANCER RESEARCH, 2009, 69
12345